Literature DB >> 15728222

Rhabdomyosarcoma: many similarities, a few philosophical differences.

Sarah S Donaldson, James R Anderson.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15728222     DOI： 10.1200/JCO.2005.11.909

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

Review 1.  Rhabdomyosarcoma of the Head and Neck: A Multimodal Approach.

Authors:  Dana L Casey; Suzanne L Wolden
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-18

2.  A concurrent episode of two neoplasms in a toddler-age child.

Authors:  Muaz A Alrazzak; Jenny Zablahalabi; Baraa Alrazzak; Guillermo De Angulo
Journal:  Avicenna J Med       Date:  2014-04

Review 3.  Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies.

Authors:  Suman Malempati; Douglas S Hawkins
Journal:  Pediatr Blood Cancer       Date:  2012-02-29       Impact factor: 3.167

4.  Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  Julie A Bradley; Mark L Kayton; Yueh-Yun Chi; Douglas S Hawkins; Jing Tian; John Breneman; Suzanne L Wolden; David Walterhouse; David A Rodeberg; Sarah S Donaldson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-20       Impact factor: 7.038

5.  Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  David O Walterhouse; Alberto S Pappo; Jane L Meza; John C Breneman; Andrea Hayes-Jordan; David M Parham; Timothy P Cripe; James R Anderson; William H Meyer; Douglas S Hawkins
Journal:  Cancer       Date:  2017-02-17       Impact factor: 6.860

6.  Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:  Abha A Gupta; James R Anderson; Alberto S Pappo; Sheri L Spunt; Roshni Dasgupta; Daniel J Indelicato; Douglas S Hawkins
Journal:  Cancer       Date:  2011-07-14       Impact factor: 6.860

7.  Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.

Authors:  John Breneman; Jane Meza; Sarah S Donaldson; R Beverly Raney; Suzanne Wolden; Jeff Michalski; Fran Laurie; David A Rodeberg; William Meyer; David Walterhouse; Douglas S Hawkins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

Review 8.  Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma.

Authors:  Amanda F Saltzman; Nicholas G Cost
Journal:  Curr Urol Rep       Date:  2018-02-22       Impact factor: 3.092

Review 9.  Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.

Authors:  Douglas S Hawkins; Sheri L Spunt; Stephen X Skapek
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

10.  Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group.

Authors:  Beverly Raney; Winston Huh; Douglas Hawkins; Andrea Hayes-Jordan; Lynn Million; David Rodeberg; Lisa Teot; James Anderson
Journal:  Pediatr Blood Cancer       Date:  2012-09-07       Impact factor: 3.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.